Current Research Studies at the Fisher Center

The Fisher Center is involved in the following genetic counseling research studies funded by the National Institutes of Health (NIH):

Personal Aid to Health (PATH): Decision Making Interventions for Women Receiving Uninformative BRCA1/2 Test Results or Positive BRCA1/2 Test Results

  • Randomized clinical trial evaluating decision support materials that supplement standard information provided during genetic counseling
  • Assesses the impact of decision support materials on patient decision-making about breast and ovarian cancer risk management strategies
  • Women may be asked to participate if they undergo genetic counseling/testing at one of these participating sites: Georgetown University Lombardi Comprehensive Cancer Center (primary site); Ohio State University Comprehensive Cancer Center (Columbus, OH), and Virginia Piper Cancer Institute (Minneapolis, MN)
  • Funded by the National Institutes of Health (National Human Genome Research Institute and National Cancer Insitute), and the Fisher Center for Hereditary Cancer and Clinical Genomics Research

*If you have been invited to participate in one of these studies or are currently entrolled and you have questions, you may contact us at 877-687-2720 (toll-free) or fisher.research@georgetown.edu

These studies are limited to individuals who receive genetic counseling at one of the participating study sites.

 

 

 

 

To make an appointment for genetic counseling and testing for hereditary cancer risk, please call (202) 444-1061

This page has been updated on 7/7/17/